Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Program for HIV Prevention and Treatment (PHPT) Study Group"'
Autor:
Nicole Ngo-Giang-Huong, Gonzague Jourdain, Billy Amzal, Pensiriwan Sang-a-gad, Rittha Lertkoonalak, Naree Eiamsirikit, Somboon Tansuphasawasdikul, Yuwadee Buranawanitchakorn, Naruepon Yutthakasemsunt, Sripetcharat Mekviwattanawong, Kenneth McIntosh, Marc Lallemant, Program for HIV Prevention and Treatment (PHPT) study group
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27427 (2011)
WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. F
Externí odkaz:
https://doaj.org/article/ec8cfed01951462fb579c9ad34cd653f
Autor:
Program for HIV Prevention and Treatment (PHPT) Study Group, Jourdain, Gonzague, Wagner, Thor Andrew, Ngo-Giang-Huong, Nicole, Sirirungsi, Wasna, Klinbuayaem, Virat, Fregonese, Federica, Nantasen, Issaren, Techapornroong, Malee, Halue, Guttiga, Nilmanat, Ampaipith, Wittayapraparat, Pakorn, Chalermpolprapa, Veeradet, Pathipvanich, Panita, Yuthavisuthi, Prapap, Frenkel, Lisa M., Lallemant, Marc
Publikováno v:
Clinical Infectious Diseases, 2010 May 01. 50(10), 1397-1404.
Externí odkaz:
https://www.jstor.org/stable/40599165